MS and PD

MS is characterized by flares that cannot be definitively linked to a physical cause.
The aetiology of MS remains unclear but may have a genetic component and is influenced by immune system attacks.
It is classified as an immune-mediated disease rather than an autoimmune disease due to its pathophysiology.

MS involves T cells and B cells, which are part of the immune response.
The immune system attacks the myelin sheath around nerves, which interferes with the process of remyelination.
This result leads to nerve damage and inflammation, manifesting as lesions in affected areas.

Lesions: Visible damage from the immune response that impacts the ability of affected nerves to transmit signals.
Remyelination attempts are hindered by aggressive immune responses, resulting in a cycle of inflammation and damage.

Gender Prevalence: More common in females than males.
Other Autoimmune Diseases: Individuals with a history of autoimmune diseases such as Thyroid disorders, type 1 diabetes, or inflammatory bowel disorder may have increased risk.
Environmental Factors: Higher incidence in temperate climates (e.g., Canada, Northern US, New Zealand, Europe).
Lifestyle Factors: Smoking is a contributing risk factor.
Infectious Agents: Epstein-Barr virus is noted to increase MS risk.
Age Factor: Most prevalent in individuals aged 15 to 60 years.

MS is currently incurable and often presents as relapses and remissions of symptoms.
Symptoms can be temporarily worsened by increased body temperature but do not indicate a relapse.

Comprehensive medical examinations paired with patient history.
Assessments focus on the central nervous system involving brain, spinal cord, and optic nerves.
Evidence of symptoms must occur at least one month apart to confirm diagnosis.
MRI scans are utilized for visualizing lesions and damage.

Motor Symptoms: Weakness and altered pain perception can lead to wheelchair dependence.
Balance and Coordination Issues: Patients may lose muscular control, requiring family education for assistance.
Altered Gait: Patients may exhibit weakness in legs and coordination leading to falls.

Visual Disturbances: Common symptoms include blurred vision, color distortion, and double vision (diplopia), the medical term being 'diplopia'.
Depth Perception Issues: Doppler or dysmetria pertains to the inability to judge distances leading to overshooting or undershooting tasks.

Loss of control over bladder and bowel functions is a recurring issue for MS patients.

Memory loss, slurred speech, and organizational difficulties are common cognitive changes.
Emotional instability (e.g., mood swings, depression) presents several challenges to patients and their families.

Patients often experience cramping and misfiring nerves that lead to muscle contractions or spasms.

The most prevalent symptoms in MS include:
- Numbness and tingling
- Vision problems
- Difficulty walking (ambulatory issues).

Current treatments are aimed at managing symptoms, improving function, and facilitating physical therapy to maintain quality of life.
Medications: (Examples)
- Baclofen and Dantrolene are muscle relaxants targeting spasticity.
- Corticosteroids may be used for acute exacerbations of MS.

Discussion around stem cell therapy, cannabis for symptom management, and mind-body therapies.
Educational Role of Nursing: Nurses provide information on available therapies but should not recommend specific treatments.

Similar in some presenting symptoms to MS but primarily impacts dopamine levels and motor control.
Dopamine Function: It's integral for mood, movement, and behavioral responses.

Genetic predispositions and environmental exposures—including head injuries—heighten susceptibility.
Age is a significant factor, with greater prevalence in individuals over 60 years old.

Symptoms range from tremors, rigidity, and bradykinesia.
Patients may also experience impaired cognitive functions and emotional disturbances.

Pharmacological treatments primarily involve Levodopa-Carbidopa, with timing and food interaction essential for effective management.
Other medications include dopamine agonists and anticholinergics, monitored for side effects such as dry mouth and urinary difficulties.

Managing Parkinson's also involves therapy and lifestyle adaptations to maintain quality of life.
Recommended scheduling includes focusing on early day engagements as patients may become fatigued as the day progresses.

Identifying symptoms and functional capacity to enable effective care planning aimed at optimal patient autonomy and quality of life is crucial for both MS and PD.